AbCellera
Our platform integrates biology, computation, and engineering to develop impactful antibody-based medicines.
- Location
- —
- Roles tracked
- 0
- In pipeline
- 0
- Tracking since
- —
At a glance
You're tracking 0 roles at AbCellera. Track a role to start building momentum here.
Company intel
From the job board · LinkedIn data via posting sync- Industry
- Biotechnology Research
- Company size
- 588 people
- Headquarters
- Vancouver, British Columbia +3 more
- Founded
- 2012
- Type
- Public Company
- Total funding
- $887.0M
AbCellera is a clinical-stage biotechnology company focused on discovering and developing antibody-based medicines in the areas of endocrinology, women’s health, immunology, and oncology.
Antibody Discovery
Cell Culture
Antibody Therapies
Protein Analysis
Microfluidic Single Cell Analysis
Single Cell Genomics
Monoclonal Antibody Discovery
Cell Enrichment
Cell Screening
Cell Recovery
Protein engineering
T cell engagers
